Recent advances in p53 research: an interdisciplinary perspective - PubMed (original) (raw)
Review
doi: 10.1038/cgt.2008.69. Epub 2008 Sep 19.
Affiliations
- PMID: 18802452
- DOI: 10.1038/cgt.2008.69
Review
Recent advances in p53 research: an interdisciplinary perspective
M Olivier et al. Cancer Gene Ther. 2009 Jan.
Abstract
The TP53 gene is one of the most studied genes in human cancer. In recent years, considerable interest was focused on mutant p53, the abnormal protein product of TP53 somatic or germline alleles with missense mutations that often accumulate in cancer cells. There is now compelling experimental evidence that many mutations can exert mutant-specific, gain-of-function effects by perturbing the regulation of expression of multiple genes. This notion is supported by the observation that targeted mutant p53 expression enhances the formation of specific cancers in the mouse even in the absence of wild-type p53 expression. In addition, clinical studies are producing a wealth of functional pathway data demonstrating correlations between specific TP53 mutations and gene expression patterns identified by transcriptome studies. These correlations imply that alteration of p53 function is critical in shaping gene expression patterns in cancer. Finally, progress is being made in the development of new therapeutic approaches targeting p53 alterations. Key advances regarding the structural, biochemical and functional properties of normal and mutant p53 proteins, their abnormal regulation and distribution in human cancers, and their associations with clinical and pathological cancer characteristics are reviewed. New opportunities for translational research for improving cancer detection, prognosis, prevention and therapy based upon the integration of this knowledge are described.
Similar articles
- The role of mutant p53 in human cancer.
Goh AM, Coffill CR, Lane DP. Goh AM, et al. J Pathol. 2011 Jan;223(2):116-26. doi: 10.1002/path.2784. Epub 2010 Oct 25. J Pathol. 2011. PMID: 21125670 Review. - Induction of genetic instability by gain-of-function p53 cancer mutants.
Xu Y. Xu Y. Oncogene. 2008 Jun 5;27(25):3501-7. doi: 10.1038/sj.onc.1211023. Epub 2008 Jan 28. Oncogene. 2008. PMID: 18223686 Review. - TP53 mutations in human cancers: functional selection and impact on cancer prognosis and outcomes.
Petitjean A, Achatz MI, Borresen-Dale AL, Hainaut P, Olivier M. Petitjean A, et al. Oncogene. 2007 Apr 2;26(15):2157-65. doi: 10.1038/sj.onc.1210302. Oncogene. 2007. PMID: 17401424 Review. - When mutant p53 plays hide and seek: a new challenge for diagnosis and therapy?
Soussi T, Hjortsberg L. Soussi T, et al. Trends Mol Med. 2009 Jan;15(1):1-4. doi: 10.1016/j.molmed.2008.11.002. Epub 2008 Dec 25. Trends Mol Med. 2009. PMID: 19097939 - Impact of mutant p53 functional properties on TP53 mutation patterns and tumor phenotype: lessons from recent developments in the IARC TP53 database.
Petitjean A, Mathe E, Kato S, Ishioka C, Tavtigian SV, Hainaut P, Olivier M. Petitjean A, et al. Hum Mutat. 2007 Jun;28(6):622-9. doi: 10.1002/humu.20495. Hum Mutat. 2007. PMID: 17311302
Cited by
- The Predictive Role of Serum Lipid Levels, p53 and ki-67, According to Molecular Subtypes in Breast Cancer: A Randomized Clinical Study.
Faur IF, Dobrescu A, Clim IA, Pasca P, Prodan-Barbulescu C, Tarta C, Neamtu AA, Brebu D, Neamtu C, Rosu M, Duta C, Clim A, Lazar G, Totolici B. Faur IF, et al. Int J Mol Sci. 2024 Mar 31;25(7):3911. doi: 10.3390/ijms25073911. Int J Mol Sci. 2024. PMID: 38612725 Free PMC article. Clinical Trial. - Tumor treating fields induced senescence on glioblastoma.
Kim EH. Kim EH. Am J Cancer Res. 2023 Nov 15;13(11):5626-5640. eCollection 2023. Am J Cancer Res. 2023. PMID: 38058802 Free PMC article. - A machine learning and directed network optimization approach to uncover TP53 regulatory patterns.
Triantafyllidis CP, Barberis A, Hartley F, Cuervo AM, Gjerga E, Charlton P, van Bijsterveldt L, Rodriguez JS, Buffa FM. Triantafyllidis CP, et al. iScience. 2023 Oct 26;26(12):108291. doi: 10.1016/j.isci.2023.108291. eCollection 2023 Dec 15. iScience. 2023. PMID: 38047081 Free PMC article. - The Importance of the Immune System and Molecular Cell Signaling Pathways in the Pathogenesis and Progression of Lung Cancer.
Smok-Kalwat J, Mertowska P, Mertowski S, Smolak K, Kozińska A, Koszałka F, Kwaśniewski W, Grywalska E, Góźdź S. Smok-Kalwat J, et al. Int J Mol Sci. 2023 Jan 12;24(2):1506. doi: 10.3390/ijms24021506. Int J Mol Sci. 2023. PMID: 36675020 Free PMC article. Review. - A role for bioinorganic chemistry in the reactivation of mutant p53 in cancer.
Miller JJ, Kwan K, Gaiddon C, Storr T. Miller JJ, et al. J Biol Inorg Chem. 2022 Aug;27(4-5):393-403. doi: 10.1007/s00775-022-01939-2. Epub 2022 Apr 30. J Biol Inorg Chem. 2022. PMID: 35488931 Review.
Publication types
MeSH terms
Substances
LinkOut - more resources
Full Text Sources
Other Literature Sources
Research Materials
Miscellaneous